Form: 10-K405

Annual report [Sections 13 and 15(d), S-K Item 405]

October 29, 1997

Documents

COMPUTATION

Published on October 29, 1997


EXHIBIT 11


ENZO BIOCHEM, INC.
COMPUTATION OF PER-SHARE EARNINGS
Years ended July 31, 1997, 1996 and 1995





1997 1996* 1995*
---- ----- -----

Primary

Average shares outstanding 23,028,000 22,593,000 22,005,200

Net effect of dilutive stock options and
warrants -- based on the treasury stock
method using average market price 1,217,000 --- 1,069,900
--------- --------- ---------

Total 24,245,000 22,593,000 23,075,100
========== ========== ==========



Net income (loss) $1,452,800 $(7,707,500) $5,618,100
========== ============ ==========



Per common and common equivalent share

Net income (loss) $.06 ($.34) $.24
==== ====== ====




*Shares and per share amounts have been adjusted for the 5% stock dividend
declared in fiscal 1995 and for the 5% stock dividend declared in September
1996.

E2